146 related articles for article (PubMed ID: 825778)
1. Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.
Smith JP; Rutledge FN
Natl Cancer Inst Monogr; 1975 Oct; 42():169-72. PubMed ID: 825778
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian carcinoma.
Kardinal CG; Luce JK
Cancer Treat Rep; 1977 Dec; 61(9):1691-3. PubMed ID: 413624
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
4. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT
Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777
[TBL] [Abstract][Full Text] [Related]
5. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Young RC; Chabner BA; Hubbard SP; Fisher RI; Bender RA; Anderson T; Simon RM; Canellos GP; DeVita VT
N Engl J Med; 1978 Dec; 299(23):1261-6. PubMed ID: 101843
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in advanced ovarian cancer.
Smith JP; Rutledge FN
Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma].
Gershanovich ML; Livshits ME; Antipenkova VI
Vopr Onkol; 2000; 46(5):604-7. PubMed ID: 11202196
[TBL] [Abstract][Full Text] [Related]
8. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.
Pater JL; Carmichael JA; Krepart GV; Fraser RC; Roy M; Kirk ME; Levitt M; Brown LB; Wilson KS; Shelley WE
Cancer Treat Rep; 1987 Mar; 71(3):277-81. PubMed ID: 3102056
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in ovarian carcinoma recurrent after radiation therapy.
Lele SB; Piver MS; Barlow JJ
Obstet Gynecol; 1978 Jan; 51(1):101-4. PubMed ID: 619324
[TBL] [Abstract][Full Text] [Related]
10. Hexamethylmelamine/altretamine as second-line therapy for epithelial ovarian carcinoma.
Moore DH; Valea F; Crumpler LS; Fowler WC
Gynecol Oncol; 1993 Oct; 51(1):109-12. PubMed ID: 8244164
[TBL] [Abstract][Full Text] [Related]
11. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Pasmantier MW; Coleman M; Silver RT; Ballard WP
Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
[TBL] [Abstract][Full Text] [Related]
12. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
Barlow JJ; Piver MS
Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.
Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM
Cancer Treat Rep; 1980; 64(2-3):323-6. PubMed ID: 6773656
[TBL] [Abstract][Full Text] [Related]
14. Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report.
Hreshchyshyn MM
Natl Cancer Inst Monogr; 1975 Oct; 42():155-65. PubMed ID: 1234633
[TBL] [Abstract][Full Text] [Related]
15. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
[TBL] [Abstract][Full Text] [Related]
16. Second trial drugs in ovarian cancer.
Stanhope CR; Smith JP; Rutledge F
Gynecol Oncol; 1977 Mar; 5(1):52-8. PubMed ID: 404216
[No Abstract] [Full Text] [Related]
17. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
Piver S; Barlow JJ; Chung WS; Lee FT; Vongtama V
Natl Cancer Inst Monogr; 1975 Oct; 42():177-82. PubMed ID: 825780
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
de Gramont A; Drolet Y; Louvet C; Dray C; Krulik M; Pigné A; Lavoie A; Painchaud M; Blouin R; Tessier C
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(1):105-9. PubMed ID: 3084619
[TBL] [Abstract][Full Text] [Related]
20. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
Chang YC; Falkson G; Tormey DC; Crowley J
Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]